Financials

  • Market Capitalization 150.67 M
  • Employee 29
  • Founded 2015
  • CEO N/A
  • Website nrxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00JCWDN63
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.59
ratio cours/chiffre d'affaires
34.34

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3737
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.63 USD-1.56%+3.28%-34.37%+52.73%153.37 M USD
3738
INDP
Indaptus Therapeutics, Inc. - Common Stock
1.15 USD+0.88%0.00%-12.88%-39.47%153.23 M USD
3749
ADCT
ADC Therapeutics SA Common Shares
1.17 USD+2.63%+18.18%+9.35%-62.14%149.37 M USD
3764
UNCY
Unicycive Therapeutics, Inc. - Common Stock
5.20 USD-1.33%-3.70%+4.00%-20.12%144.85 M USD

Nouvelles